ERBB2 and breast carcinoma: Based on the incorporation of biologic factors (histologic grade, estrogen receptor, progesterone receptor, HER2, and multigene panels) to the classic anatomic stage, the 8th edition of the AJCC breast cancer staging system has introduced prognostic stage, which was developed using data from patients identified in the National Cancer Database (2010–2011) and then validated in large cohorts of patients from the MD Anderson Cancer Center and the California Cancer Registry [2–7].